Indication

Corticobasal syndrome

1 clinical trial

1 product

1 drug

Clinical trial

Double-blind, Randomised, Prospective, Placebo Controlled Parallel Group Phase II Study to Investigate the Effect of Glycerol Phenylbutyrate (GPB) on Neurofilament Light Chain (NfL) Levels in Patients With Corticobasal Syndrome (CBS)

Status: Recruiting, Estimated PCD: 2024-08-01

Product

Drug